CA Patent

CA2286076C — Use of 5ht3 antagonists for promoting intestinal lavage

Assigned to Janssen Pharmaceutica NV · Expires 2006-12-12 · 19y expired

What this patent protects

The present invention is concerned with the use of 5HT3 antagonists for promoting intestinal lavage, especially in combination with an osmotic agent.

USPTO Abstract

The present invention is concerned with the use of 5HT3 antagonists for promoting intestinal lavage, especially in combination with an osmotic agent.

Drugs covered by this patent

Magnesium Sulfate (Magnesium Sulfate) · Pfizer

Patent Metadata

Patent number: CA2286076C
Jurisdiction: CA
Classification: —
Expires: 2006-12-12
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Pharmaceutica NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.